Skip Navigation


Biostatistics Advance Access originally published online on October 4, 2006
Biostatistics 2007 8(3):576-594; doi:10.1093/biostatistics/kxl030
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
8/3/576    most recent
kxl030v2
kxl030v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lambert, P. C.
Right arrow Articles by Dickman, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lambert, P. C.
Right arrow Articles by Dickman, P. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

Estimating and modeling the cure fraction in population-based cancer survival analysis

Paul C. Lambert* and John R. Thompson

Department of Health Sciences, Centre for Biostatistics and Genetic Epidemiology, University of Leicester, 22-28 Princess Road West, Leicester LE1 6TP, UK, pl4{at}le.ac.uk

Claire L. Weston

United Kingdom Children's Cancer Study Group, University of Leicester, Leicester, UK

Paul W. Dickman

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

* To whom correspondence should be addressed.

In population-based cancer studies, cure is said to occur when the mortality (hazard) rate in the diseased group of individuals returns to the same level as that expected in the general population. The cure fraction (the proportion of patients cured of disease) is of interest to patients and is a useful measure to monitor trends in survival of curable disease. There are 2 main types of cure fraction model, the mixture cure fraction model and the non-mixture cure fraction model, with most previous work concentrating on the mixture cure fraction model. In this paper, we extend the parametric non-mixture cure fraction model to incorporate background mortality, thus providing estimates of the cure fraction in population-based cancer studies. We compare the estimates of relative survival and the cure fraction between the 2 types of model and also investigate the importance of modeling the ancillary parameters in the selected parametric distribution for both types of model.

Keywords: Cure models; Relative survival; Survival analysis

Received March 9, 2006; revised August 11, 2006; accepted for publication September 29, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
L. M. Woods, B. Rachet, P. C. Lambert, and M. P. Coleman
'Cure' from breast cancer among two populations of women followed for 23 years after diagnosis
Ann. Onc., August 1, 2009; 20(8): 1331 - 1336.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.